Blocking receptor signals can help treat fibrosis
In an investigator-initiated trial, researchers have shown that inhibiting the cytokines IL-4 and IL-13 can prevent fibrosis in the skin disease localized scleroderma. These findings could pave the way for the prevention and treatment of other fibrotic conditions. The study "Interleukin 4 receptor-α blockade in localised scleroderma: a phase II proof-of-concept study" was published in the journal…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.